Tel: +44(0)20 7691 0984 Email: Newsletter Sign Up
  • CEO Mark Duxon interviewed by The Pharma Letter on impact of Brexit on CROs...
  • Announcing new premises in Poland with a focus on neuropsychiatric disorders...
  • State-of-the-art premises opening this month at Discovery Park in Kent...
  • Newly published work in Frontiers in Psychiatry demonstrating
  • the effectiveness of a clinically relevant dose of ketamine...
  • Head to 2021 conferences page to see titles of abstracts...


All the latest conference updates; those that we are attending and the studies that we are presenting

neuroscience irelandTranspharmation Ltd are pleased to sponsor Neuroscience Ireland’s Young Investigator Symposium, taking place on 6th November in Dublin We’re also delighted that one of our young scientists, Erwina Stojek, has been selected to talk about her recent study on a new therapeutic target for aggressive behaviour. If you would like to see Erwina’s study or find out more about how we could help with your studies, please contact us This email address is being protected from spambots. You need JavaScript enabled to view it.   


Start a Conversation

uk flag+44 (0)20 7691 0984

ireland flag+353 (0)1896 42 60

poland flag+48 515 244 120



Copyright © 2021 Transpharmation Ltd. All Rights Reserved.

Copyright © 2019 Transpharmation Ltd. All Rights Reserved. Website created by Identity Ipswich Web Design